Izidakamizwa "Lerivon". imiyalelo ukusetshenziswa kwaso.

"Lerivon" - umuthi ezihlobene antidepressant. Ukuze bakwazi bajwayelane isakhiwo futhi bathole ezinye zezici zalo njalo exhunywe izidakamizwa "Lerivon" imfundiso.

Isakhiwo "lerivon" kuyinto asebenzayo izidakamizwa izidakamizwa - hydrochloride mianserin (30 mg), kanye izithako asizayo: magnesium stearate, amazambane isitashi, meliltsellyuloza, kalloidny Silica anhydrous, i-calcium ne-phosphate, ama-titanium dioxide (E 171), macrogol, hypromellose.

I asebenzayo izidakamizwa mianserin siphathelene compounds piperazino-azepine zazo amakhemikhali ezihlobene tricyclic antidepressant. "Lerivon" ivinjiwe alpha2 yokwamukela futhi kuvimbela reuptake ka norepinephrine, ngaleyo ndlela kwande ukudluliswa ubuchopho noradrenergic. Futhi sesiyabazi nokuxhumana serotinovymi nge zemizwa isimiso sezinzwa esiyinhloko. Umuthi Ubuye umphumela anxiolytic, okuyinto ebaluleke kakhulu ekwelapheni yokukhathazeka futhi izinkinga zokulala, okuyinto zibangelwa jikelele isimo ecindezelekile yomuntu.

Njengoba unamathele izidakamizwa "Lerivon" La mazwi abonisa ukuthi isidakamizwa kahle ikubekezelele iziguli ezine yezifo esimiso senhliziyo nemithambo yegazi, kanye nasebekhulile. Ngezinye ngemithamo ukuthi kukhona therapeutically ngempumelelo "Lerivon" has cishe akunamthelela yisimiso senhliziyo nemithambo yegazi. Akayena eziyizici umsebenzi anticholinergic. It has nemiphumela kancane cardiotoxic e ukweqisa izidakamizwa kuka tritseklicheskie antidepressant. "Lerivon" akusho ubheke abamelene antihypertensive namanxusa sympathomimetic.

izidakamizwa ezisetshenzisiwe "Lerivon 'ku ayimigodi of etiologies ehlukahlukene. Nokho, kukhona Izimo ambalwa. Ukuze wazi abathengi nabo exhunywe izidakamizwa "Lerivon" imfundiso. Ifunde ngokuningiliziwe, ungabona ukuthi akunakwenzeka ukwamukela "Lerivon": uma hypersensitivity kuya izidakamizwa esebenzayo - mianserin noma iyiphi izingxenye ezihambisana; izingane nentsha eneminyaka engaphansi 18; yezifo kwesibindi kanye ukwephulwa ezinzima imisebenzi yawo ngokupheleleko.

Okumele kuqashelwe ukuthatha leli izindleko kwezidakamizwa nabantu izinso noma isibindi ukwehluleka, ezingamahlalakhona ukumelwa inhliziyo, engela-Ukuvalwa glaucoma, isifo sikashukela, hypertrophy Prostatic. Ngokuqondene inkathi nokukhulelwa kanye lactation, unamathele izidakamizwa "Lerivon" imfundo ikuvumela ukuba bafunde ukwaziswa ucwaningo yayiqhutshelwa ezilwaneni kanye eqoqwe maqondana nomuntu, idatha elinganiselwe. Kulesi sisekelo, kwatholakala ukuthi mianserin ayinakho neontalnogo noma ukulimala intrauterine. Ngaphezu kwalokho kwatholakala ukuthi mianserin ugxile obisini lwebele imali omncane. Nokho, naphezu kwalokhu ngaphambi kokwenza "Lerivon" lapho ondla noma ukukhulelwa, kumelwe qhathanisa kuzuze izidakamizwa nge ingozi engaba ezingenzeka embungwini nengane.

Ungafunda mayelana okwelapha umkhiqizo "Lerivon" Izibuyekezo phambi Ukulisebenzisa ngokuqondile kanjena izidakamizwa. Kusukela Izibuyekezo ungakwazi ngezinye izikhathi uthole ulwazi olubalulekile. Ngokwesibonelo, ungafunda kabanzi mayelana nezinye imiphumela emibi: ngokuvamile kakhulu somnolence; ngezinye izikhathi anda esisindo; echazwe njengo Ezimweni ezingavamile kakhulu agranulocytosis, esethola ukuthuthukiswa leukopenia, amajaqamba, arthralgia, gynecomastia, edema, ukuwohloka umsebenzi sesibindi.

Njengoba unamathele izidakamizwa "imiyalelo Lerivon 'ukusetshenziswa is hhayi kuhloselwe izinjongo self-ukwelashwa kanye inkomba kuphela. Kuyadingeka ukuthatha leli ku-akhawunti ngaphambi kokusetshenziswa kwezidakamizwa. Ukwelashwa udokotela.